Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) General Information

Description

Global rights of cell expansion, immune cell infiltration, and cancer cell killing product candidate used for metastatic colorectal cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Rockville, MD
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Rockville, MD
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer)‘s full profile, request access.

Request a free trial

Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer)‘s full profile, request access.

Request a free trial

Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) FAQs

  • Where is Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) headquartered?

    Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) is headquartered in Rockville, MD.

  • What industry is Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) in?

    Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer)’s primary industry is Buildings and Property.

  • Is Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) a private or public company?

    Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) is a Private company.

  • What is the current valuation of Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer)?

    The current valuation of Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) is .

  • What is Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer)’s current revenue?

    The current revenue for Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) is .

  • Who are Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer)’s investors?

    Innovative Cellular Therapeutics has invested in Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer).

  • When was Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) acquired?

    Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) was acquired on 10-Nov-2025.

  • Who acquired Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer)?

    Innovative Cellular Therapeutics (Global Rights of CAR T-Cell Candidate for Colorectal Cancer) was acquired by Lyell Immunopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process